MNTA
Momenta Pharmaceuticals, Inc.
MNTA
MNTA
Delisted
MNTA was delisted on the 30th of September, 2020.
158 hedge funds and large institutions have $1.36B invested in Momenta Pharmaceuticals, Inc. in 2017 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 74 increasing their positions, 33 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
4% less funds holding
Funds holding: 164 → 158 (-6)
22% less first-time investments, than exits
New positions opened: 14 | Existing positions closed: 18
Holders
158
Holding in Top 10
1
Calls
$3.65M
Puts
$644K
Top Buyers
| 1 | +$25.5M | |
| 2 | +$18.3M | |
| 3 | +$12M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$6.35M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$5.64M |
Top Sellers
| 1 | -$20.8M | |
| 2 | -$12.7M | |
| 3 | -$5.28M | |
| 4 |
Goldman Sachs
New York
|
-$4.24M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$4.1M |